Acupuncture for Dysphagia After Chemoradiation Therapy in Head and Neck Cancer Patients: A Pilot Randomized Control Trial
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care
MDADI will be measured at baseline, 4 weeks, 8 weeks, 12 weeks, 20 weeks post CRT and 6 months follow up (12 mo from baseline).
M.D. Anderson Dysphagia Inventory (MDADI) is used for the primary outcome measure.
baseline, 4 weeks, 8 weeks, 12 weeks, 20 weeks post CRT, and 6 months followup ( 12 mo from baseline)
Weidong Lu, MB, MPH, PhD
Harvard Medical School/Dana-Farber Cancer Institute
United States: Federal Government
|Dana-Farber Cancer Institute||Boston, Massachusetts 02115|